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Background: Smoking remains the leading cause of preventable illness and mortality in the United States.
Individuals with Posttraumatic Stress Disorder (PTSD) have smoking rates higher than that of others and fewer
individuals with PTSD have quit smoking. This randomized controlled trial was designed to test the effectiveness of
integrating telehealth care management and smoking cessation with motivational interviewing for Veterans with PTSD.
Methods/Design: All smokers with PTSD, regardless of their desire to quit, were invited to participate. Enrollment
occurred between November 2009 and April 2013. Target enrollment was 120 participants. Enrolled participants
were randomized to either the control group, receiving usual care including a telehealth PTSD program, with a
device that delivered PTSD information and in-home care management, or the intervention group, which included
(1) a telehealth PTSD program, (2) motivational interviewing-based smoking cessation curricula via the telehealth
device, and (3) weekly motivational interviewing counseling phone calls. Outcomes are self-reported 24-hour quit
attempts, progression along the stages of change and 7-day point prevalence quit smoking rates for the intervention
group compared to usual care alone. Secondary outcomes include participants’ perception of care coordination,
patient satisfaction with motivational interviewing, PTSD symptoms, pain, depression and quality of life.
Discussion: Motivational interviewing has been shown to increase readiness for change and smoking cessation care
has been shown to be more successful when incorporated into in-person mental health care. Our study builds on
previous studies. It integrates a written smoking cessation curriculum and phone-based motivational interviewing
counseling into an established PTSD home telehealth care coordination program. This paper describes the design and
methods of our randomized control trial.
Trial registration: ClinicalTrials.gov, NCT00908882, May 22, 2009.
Keywords: Smoking cessation, Posttraumatic Stress Disorder, PTSD, Telehealth, Motivational interviewing, VeteranBackground
Individuals with Posttraumatic Stress Disorder (PTSD)
who smoke represent a challenge to the Veterans Health
Administration (VHA). Smoking remains an important
cause of preventable illness and mortality [1] and is re-
sponsible for over 435,000 deaths per year [2]. Indi-
viduals with PTSD smoke at higher rates than those
without mental illness [3] and only half as many indivi-
duals with PTSD have quit smoking as compared to* Correspondence: jamie.peterson@va.gov
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unless otherwise stated.those without mental illness [3]. As individuals expe-
rience reductions in all-cause mortality when they quit
smoking, even a small increase in quit rates can improve
health and life expectancy [4].
A bidirectional causal relationship is the likely cause
for the difficulty individuals with PTSD have in quitting
smoking [5]. On one hand smoking can increase PTSD
symptoms such as hyperarousal and avoidance [6].
While on the other hand, nicotine can temporarily re-
duce anxiety and create a positive effect on mood [7].
This dichotomy can be most effectively addressed in
mental health treatment, and integrating smoking cessa-
tion care into mental health treatment has been foundal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ever, tobacco cessation is not well integrated into
ongoing mental health care. It tends to be brief and epi-
sodic, and lack of time during an appointment has been
shown to be a major barrier for mental health providers
in delivering smoking cessation counseling [9].
Although tobacco cessation programs are available in
most VHA medical facilities, the rate of Veterans taking
advantage of such programs has traditionally been low;
only 17% of Veterans who are most interested in quit-
ting participate in a smoking cessation program [10].
The distance that many Veterans live from medical cen-
ters contributes to the difficulty accessing health care.
Most services are provided at tertiary care centers in
major cities whereas approximately 28% of Veterans live
in rural areas [11].
Home telehealth platforms with care coordination
used by the VHA have been shown to decrease uti-
lization of health care resources and have a mean satis-
faction score rating of 86%, according to routine analysis
of data from a cohort of 17,025 users [12]. It has also
been shown to improve outcomes for high-risk and
high-use individuals [13], such as those with PTSD.
Since patients with PTSD tend to avoid activities and
struggle to be around others [14], home telehealth can
help these high-risk patients feel connected and less iso-
lated. Integrating smoking cessation into a home tele-
health program for patients with PTSD is an innovative
alternative to incorporating smoking cessation services
in mental health care.
Motivational interviewing (MI) is a behavioral coun-
seling approach that has been shown to be effective in
helping people abstain from negative behaviors by re-
solving ambivalence about behavior and increasing
internal motivation [15]. MI has also been shown to in-
crease smoking cessation [16] when compared with brief
counseling or usual care [17]. This counseling style is
typically done in verbal exchanges and has been shown
to have greater effects when conducted in multiple
sessions of greater than 20 minutes [17]. However, the
currently tested method creates a barrier for integration
into already busy mental health clinics as it requires
significant time.
A pilot study testing fidelity and feasibility was com-
pleted prior to starting this trial. It showed that it was
feasible to deliver home telehealth care management
with high treatment fidelity [18]. Based on the results of
this pilot study, we developed a randomized controlled
trial (RCT) to facilitate smoking cessation in Veterans
with PTSD. We integrated a written smoking cessation
curriculum and telephone MI counseling into the estab-
lished PTSD home telehealth care coordination pro-
gram. This paper describes the design and methods of
our RCT.Methods/Design
Study design overview
This single center randomized trial is funded by the
Department of Veterans Affairs Health Services Research
and Development Service. It tests the effectiveness of
integrated care management using telehealth and MI tele-
phone counseling for smoking cessation treatment for
Veterans with PTSD (Figure 1). A total of 120 participants
were targeted for enrollment. Primary outcomes are
self-reported quit attempts as measured by 24-hour point
prevalence, perception of care coordination, and PTSD
symptoms. Additional outcomes include progression
along the stages of change and 7-day point prevalence
quit rate. Outcome data will be measured at the end of
the intervention period (month 3) and 6 months post-
intervention (month 9). This study followed all applicable
IRB regulations and was approved by the Colorado
Multiple Institutional Review Board.
Study population
All eligible smokers are offered enrollment, regardless of
their desire to quit smoking.
Inclusion criteria include: Veterans that have a Diagnostic
and Statistical Manual of Mental Disorders IV (DSM-IV)
criteria for diagnosis code 309.81 PTSD documented in
their medical record, willingness to participate, 18 years or
older and currently smoking one or more cigarettes per
day at the time of recruitment. Inclusion criteria initially
included smoking ten or more cigarettes per day but was
lowered to expand the pool of potential enrollees, while
ensuring participation of daily smokers.
Exclusion criteria include: Veterans who use smokeless
tobacco, pipes or cigars instead of cigarettes, have im-
minent risk of suicide or violence, have severe psy-
chiatric symptoms or psychosocial instability likely to
prevent participation in protocol (mental health or pri-
mary care provider will assess appropriateness), have
clinically apparent, gross cognitive impairment, do not
have telephone access and/or are unable to connect to
the telehealth appliance in their home.
Control group
Participants randomized to the control group will re-
ceive information programmed into the usual PTSD
Health Buddy program, care coordination and usual care
for smoking cessation.
Intervention group
Participants randomized to the intervention group will
receive (1) information programmed into the usual
PTSD Health Buddy program, care coordination and
usual care for smoking cessation (2) stage-based, MI
smoking cessation curriculum on the Health Buddy, and
(3) weekly telephone MI counseling with a nurse.
Figure 1 Study design.
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Written consent to participate is obtained. Recruitment
occurred between November 2009 and April 2013. Re-
cruitment is performed by creating and posting an infor-
mational flyer in high traffic areas in the VHA hospital
and community-based outpatient clinics. It is geared to-
ward potential patients and explains goals and objectives
of the study, eligibility criteria and enrollment process.
Patients are also approached in the VHA Tobacco Risk
Clinic and VHA mental health and smoking support
groups to offer participation. Additionally, primary care
and mental health providers are educated about the
study and their assistance in identifying eligible patients
is enlisted.Recruitment is also performed utilizing Electronic
Medical Record screening and the mail. Names, addresses,
and primary care provider of potential subjects from the
VHA database who have the ICD-9 codes 309.81 (PTSD)
and 305.1 (Tobacco Use Disorder) in their medical record
are identified. An invitation to participate in the study, an
information sheet, a questionnaire and a refusal card are
sent addressed from the primary care provider via the U.S.
Mail. If the potential subject returns the questionnaire,
he/she will be contacted for possible enrollment by a
member of the research team. If the potential subject
returns the refusal postcard, the subject’s name is re-
moved. If no response is received, the potential subject
will receive up to two more reminder letters. If no
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name will be removed from the database.
Intervention
All participants receive the PTSD home telehealth pro-
gram during the intervention portion of the study. Only
the intervention group receives smoking cessation infor-
mation via home telehealth and MI counseling by a
nurse (Figure 2). The care coordinator working with the
intervention group is trained in MI, whereas the care co-
ordinator working with the control group provides usual
care.
Home telehealth, as provided via the Health Buddy®
appliance (Bosch Healthcare, Palo Alto, CA), is a chronic
disease management tool used by the VHA (Figure 3).
The Health Buddy is a 12 inch × 8 inch × 4 inch
computer-like appliance, consisting of a LCD screen and
four large buttons, used by patients to enter responses.
Individuals use the Health Buddy daily from their home,
answering questions and reading messages that areFigure 2 Intervention components.displayed on the screen. A typical session takes one to
three minutes to complete. The device’s questions aim
to assess symptoms, behaviors and knowledge related to
an individual’s PTSD. An example of a question in the
PTSD module is “On a scale from 1–10, please report
your highest anger rating in the past three days”. The
device automatically transmits the patients’ responses
during the night to a secure data center and questions
for the next day are downloaded into the appliance.
A nurse care coordinator reads responses daily, moni-
toring for gradual changes in individuals’ status and inter-
vening only in acute or urgent care needs. Responses are
color-coded and flagged according to pre-determined cri-
teria to facilitate rapid interpretation. As all responses for
a given individual are summarized, the care coordinator
can determine at a glance whether or not a person is ex-
periencing significant problems. When deterioration in
clinical status is detected, the care coordinator will contact
the individual via telephone to verify the accuracy of re-
sponses and acquire further information. Depending on
Figure 3 Health Buddy device.
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counseling or discuss the person with the primary care or
mental health provider for subsequent recommendations.
Data are accessed by logging onto a secure VHA intranet
site to review responses daily during the regular work
week.
The Health Buddy home telehealth intervention aims
to promote self-care management which is a pillar of
the Chronic Care Model [19,20]. It gives patients with
chronic conditions support and guidance in order to
encourage daily decisions that improve health-related
behaviors and clinical outcomes. Self-management sup-
port is patient-centered and offers patients a variety of
tools or techniques that help them choose healthy be-
haviors and transforms the patient-caregiver relationship
into a collaborative partnership [21]. Through the PTSD
Health Buddy, the patient will receive information about
managing his/her multiple chronic conditions that foster
self-management.
Integrated within the PTSD Health Buddy, the inter-
vention utilizes the Transtheoretical Model of Change
(TTM) as the theoretical framework on which to struc-
ture the MI curriculum and counseling. TTM [22,23] is
based on the principle that individuals are at various
stages of readiness to make a behavior change, like quit-
ting smoking. As individuals progress towards making a
change to a behavior, they move along categories re-
ferred to as the stages of change. Our conceptual model
(Figure 4) is based on both the Chronic Care Model and
the TTM. We hypothesize behavior change will result
from strengthening self-management skills and enhan-
cing motivation to move along the stages of change.
Participants are asked to use the research Health Buddy
daily for 90 sessions (the intervention period). During the
follow up period (final six months), monthly calls are
made by the research staff to gather smoking data. If any
participant wants to continue to use the Health Buddyafter the intervention period, the individual’s telehealth
care is transferred to the VHA’s Care Coordination Home
Telehealth Department and they use the standard PTSD
Health Buddy program.
All participants have access to usual tobacco cessation
care at the VHA, which includes a specialty tobacco ces-
sation clinic, a tobacco cessation support group in the
mental health clinic, a month long tobacco cessation
educational group, and/or treatment within the primary
care setting. All first line medications are available to
study participants, including bupropion SR, nicotine
gum, nicotine lozenge, nicotine patch. Varenicline, nico-
tine nasal spray and nicotine inhaler use is restricted by
the VHA for use by those who failed other medication
therapies. In order to utilize existing treatment moda-
lities, study nurses assess participants’ desire to use a
medication and, if interested, a referral is made to exis-
ting providers.
Consistent with MI principles, participants will make
choices about how and when to participate. We acknow-
ledge that not all participants will chose to answer the
Health Buddy questions daily or to be available for their
counseling call weekly.
Smoking cessation curriculum
The research team developed a 90-session smoking ces-
sation curriculum based on the principles of TTM and
MI that is integrated with the PTSD curricula. Using
branching-chain logic, each session provides stage-based
information or questions about readiness to quit smok-
ing, process of change and a commitment to take action.
An example of a question is “On a scale of 1 to 10 (with
1 being not confident and 10 being very confident), how
confident are you that you are capable of quitting?”
Motivational interviewing counseling
The intervention group will participate in weekly coun-
seling calls. Interactions with the research nurse are
based on stage of change and responses to the home tel-
ehealth smoking cessation curriculum. MI techniques
such as 1) giving advice as requested, 2) removing bar-
riers, 3) providing choice, 4) decreasing desirability, 5)
practicing empathy, 6) providing feedback, 7) clarifying
goals, and 8) actively helping [15,24] are utilized. MI
techniques will vary based on stage of change. For ex-
ample, the individual in pre-contemplation is not cur-
rently considering a change. The care coordinator will
validate lack of readiness, respect autonomy, encourage
re-evaluation, and ask permission when explaining risks.
To ensure fidelity, random calls made by the interven-
tion research nurse are observed throughout the study.
Additionally, the research nurse will participate in on-
going MI training and workshops throughout the study
to diminish “drift” away from the principles of MI.
Figure 4 Conceptual model.
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The study has three objectives; each has a primary out-
come and secondary endpoints. Secondary outcomes are
exploratory and supportive of the primary outcomes.
In objective one, we will compare the (1) proportion
of individuals that make a self-reported 24-hour quit at-
tempt, (2) progression through the stages of change
[25,26] and (3) 7-day point prevalence quit smoking
rates for the intervention group to usual care alone. The
primary outcome is the proportion of participants
making a self-reported quit attempt in each group
during the study period. Secondary outcomes are the
proportions of individuals who make a progression in
their stage of change and quit smoking, as measured by
a 7-day point prevalence, between study entry, end of
intervention (month 3) and at 6 months post-intervention
(month 9). Quit attempts will be bioverified by expired
carbon monoxide levels (a CO level of less than or equal
to ten will be considered non-smoking) [27] during in-
person visits at the 3 month and 6 month follow-up
periods. Subjects who do not respond will be classified as
continuing smokers.
In objective two, we will compare the patient per-
ception of care coordination for the intervention group
to usual care alone. The primary outcome is the mean
score change of the participant’s perception of care
coordination (PACIC) [28,29] from baseline to end of
intervention (month 3), and 6 months post-intervention
(month 9) periods. Secondary endpoints of interest are
an evaluation of the intervention from the participants’
perspective via two satisfaction surveys (one for stage-
based/MI smoking cessation Health Buddy written con-
tent and one for the nurse-driven MI intervention).
Patient satisfaction will be evaluated for the intervention
group only at the end of the intervention (month 3).In objective three, we will compare PTSD symptoms
of participants who receive the intervention to those re-
ceiving usual care alone. The primary outcome is the
mean score change of PTSD symptoms utilizing the
Posttraumatic Stress Disorder Checklist [30] from base-
line to end of intervention (month 3), and 6 months
post-intervention (month 9). Secondary endpoints of
interest are the mean score change for the following sur-
vey results and will be compared from baseline to end of
intervention (month 3) and 6 months post-intervention
(month 9):
 Depression: Change in depressive symptoms
measured by the Geriatric Depression Screen
(GDS) [31,32]
 Chronic Pain: Change in chronic pain symptoms
measured by the McGill Short Form Pain
Questionnaire [33]
 Health Status: Change in the Health Care Related
Quality of Life measured by the Veterans Rand-12
(VR-12) [34,35]
Sample size calculations were based on testing the ef-
fectiveness of the intervention, compared to the control
group, in higher rate of quit attempts and progression in
the stage of change, better perceived care coordination,
and improved PTSD symptoms. Only the trend of quit
rate differences will be examined since the study sample
will include those who are not ready to quit. Initially we
expected to enroll 140 subjects in order to obtain 120
completers, anticipating a 12-15% drop out rate. How-
ever, due to a higher than expected loss to follow up rate
enrollment was expanded to target 180 participants.
Statistical analyses will be done using SAS (Cary, NC).
Objective one involves comparison of two proportions
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With 120 subjects, equally allocated between the two
groups, 24% absolute difference in rates at 3 months can
be detected for a two-sided test of proportions between
two groups at a 5% Type I error rate and 80% power.
Objective two and three involve comparison of means
across two groups for perceived care coordination and
PTSD symptoms. Effect size of 0.1, 0.25 and 0.4 (or
equivalently mean difference of 0.2, 0.5, 0.8 in standard
deviation units between two groups) are typically defined
as small, medium, and large. By recruiting the 120 sub-
jects for objective one, a medium effect size in percep-
tion of care coordination and PTSD symptoms can be
detected for a two-sided test of means between two
groups at a 5% Type I error rate and 80% power. We will
consider this finding to be clinically significant if inter-
vention group Veterans perceive their care to be better
coordinated and they experienced less PTSD symptoms.
Data collection
Outcomes are assessed at the end of the intervention
period (month three) and six months post-intervention
(month 9). Data collection occurs at baseline, at set
points during the intervention period, at the end of the
intervention period (month 3), at set points during the
follow-up period, and six months post-intervention
(month 9). Many survey questions are entered into the
Health Buddy program and then answered by the partic-
ipants via the appliance. Each subject will attend an in-
person study visit at designated times to complete sur-
veys not able to be performed via the Health Buddy. A
small incentive will be given to subjects (total of $24 for
three visits) to help defray associated costs.
Baseline data include expired carbon monoxide level,
McGill Pain Questionnaire (both done at in-person
enrollment), PACIC, PTSD Checklist, Stage of Change,
Fagerström Test of Nicotine Dependence [36], GDS, and
VR-12. As these surveys, except when noted, are imple-
mented via the Health Buddy and done at home by the
participant, not all baseline survey results are recorded
on the day of enrollment.
During the intervention period, a 24-hour cigarette re-
call is asked via the Health Buddy weekly. Stage of
change and suicide risk are assessed monthly via the
Health Buddy during the intervention portion of the
study. At the end of the intervention period, the follo-
wing data are collected: expired carbon monoxide level,
McGill Pain Questionnaire (both done in person),
PACIC, PTSD Checklist, Stage of Change, GDS, and
VR-12. Participant satisfaction with the MI written con-
tent and the MI counseling calls is assessed at this time,
as well. Unless otherwise noted, surveys are completed
on the Health Buddy and therefore all participants do
not complete them on the same day; it is dependent onhow many days a week the Health Buddy is used by a
participant.
During the six month follow-up period, stage of
change and a 24-hour cigarette recall are asked monthly.
At the end of the six-month follow-up, participation in
the study ends and the following additional data are
collected: expired carbon monoxide level, McGill Pain
Questionnaire (both done in person), PACIC, PTSD
Checklist, Stage of Change, GDS, and VR-12.
Data analysis
All analyses will be conducted using the intention to
treat principle. We will describe baseline characteristics
by study groups and test for differences in age, gender,
PTSD symptoms, depressive symptoms, suicide risk,
chronic pain, medical co-morbidities, co-morbid mental
health disorders and other patient attributes. If noted, we
will account for significant differences in the analyses.
Analysis of objective one, primary outcome: We will
test the primary hypothesis by comparing dichotomous
variables, self-reported quit attempts as the outcome
variable at the end of the intervention period (3 months)
and the end of the follow-up period (6 months post-
intervention) between the two study arms using chi-
square tests. Then, to account for potential imbalance in
baseline characteristics and to improve the precision of es-
timates, we will test the primary hypothesis using a logistic
regression model with quit attempts as the outcome va-
riable and include baseline characteristics, tobacco de-
pendence, selected baseline variables, and study group as
independent variables.
Analysis of objective one, secondary outcomes: Changes
in readiness stages and smoking cessation will be com-
pared between arms using chi-square tests. Then, to
improve the precision of estimates, we will test the sec-
ondary outcomes using a logistic regression model. This
model will use the changes in stage of change and smo-
king cessation as the dependent variables and baseline
characteristics, tobacco dependence, selected baseline
variables, and study group as independent variables.
Analysis of objectives two and three, primary out-
comes: We will test the primary objectives for objectives
two and three by comparing means (or changes in
means) of continuous variables, patient’s perception of
care coordination and PTSD symptoms at the end of the
intervention period (3 months) and the end of the
follow-up period (6 months post-intervention) between
the two study arms using the Student’s t-test. Then, to
account for any imbalance in baseline characteristics
and to improve the precision of estimates, we will test
the primary objectives of these hypotheses using a mul-
tiple linear regression model. This model will use the
perception of care coordination primary outcome as the
dependent variable (and PTSD symptoms) and include
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baseline variables, and study group as independent
variables.
Analysis of outcomes for objectives two and three,
secondary outcomes: Mean scores (or changes in the
mean scores) of standardized instruments will be used
to assess depression, suicide risk, chronic pain, and
health related quality of life in all subjects. These are
all continuous outcomes so we will use the t-tests
and linear regression to determine intervention
effects.
Discussion
This study incorporates a written and verbal MI-
based intervention by a nurse into a currently used
home telehealth care coordination platform for Vet-
erans with PTSD who smoke. We feel this program
is unique and important for several reasons. One, it
has the potential to facilitate utilization through in-
creased access to smoking cessation care via use of
telehealth and phone calls. This expands reach to
Veterans who live at a significant distance from ter-
tiary care centers or have difficulty obtaining clinic
services due to PTSD symptoms or stigma. Two, it
can potentially increase smoking cessation rates
through incorporation of a smoking cessation pro-
gram into a currently established mental health ser-
vice for individuals with PTSD. Three, it increases
the dose of the intervention without significant extra
cost or time by using daily dosed written curricula.
Finally, it tests the impact of a nurse-implemented
MI counseling intervention.
This intervention attempts to alleviate barriers Vet-
erans with PTSD face when accessing smoking cessation
treatment. Its strength lies in its ability to provide smok-
ing cessation and mental health care services via tele-
health and the telephone. Providing care over the
telephone is one way to increase availability of services.
This intervention thereby facilitates the ease of inter-
action by providing in-home services, which decreases
monetary and time resources spent traveling to a clinic
for care. It also reduces potential stigma experienced
when entering a VHA mental health clinic. Furthermore,
it provides an opportunity for those living in very rural
areas to utilize previously inaccessible smoking cessation
treatment.
As smoking cessation interventions have been shown
to be more successful when integrated into face-to-face
mental health care visits [8], this intervention was de-
signed to be easily implemented into current home tele-
monitoring mental health care. It is a comprehensive
and intense approach that provides both mental health
and smoking cessation services to Veterans with PTSD
daily via the home telehealth platform, through weeklyscheduled MI counseling calls, and, as needed, for im-
mediate mental health issues and/or changes. It further
tests the efficacy of the incorporation of smoking cessation
care into mental health services by testing the delivery of
an intervention over the phone and via telehealth. The
Health Buddy platform is currently used nationally in the
VHA for many diagnoses, including chronic obstructive
pulmonary disease, congestive heart failure, diabetes and
depression. It is a large chronic disease management ini-
tiative for the VHA; it was introduced in 2003 and aimed
to have 92,000 enrollees by the end of 2012 [37]. Smoking
cessation curricula could be easily added to any currently
offered disease management program, and thus could
reach many smokers quickly and easily. If shown to be ef-
fective, the ease of implementation of this program into
currently in-use, established medical care is a strength of
this intervention.
To our knowledge, limited studies have examined the
effect of print-based MI interventions on behavior
change. For this study, the research team wrote a smo-
king cessation curriculum using the tenants of MI.
Smoking cessation assistance is administered via the tel-
ehealth appliance to the participant every day the Health
Buddy is used for 90 sessions. Thus, the participant re-
ceives smoking cessation information more frequently
than is typically administered in a class or counseling
session. If successful, this method is a cost effective way
to deliver frequent smoking cessation information to a
large number of participants.
Nurses are ideal implementers because they have experi-
ence in teaching and increasing self-management and
positive behaviors and have been shown to successfully
manage chronic diseases via telehealth [38,39]. They have
also been shown to improve health outcomes through the
use of counseling and motivational approaches [18,40].
Additionally, because all care is telephone-based, the
nurse is not bound by appointment times, allowing for
more flexibility depending on individual needs of the pa-
tient. The average length of every phone call is recorded
in the study. Ability of the care coordinators to deliver the
intervention with high fidelity was tested and validated in
the pilot study [18].
Another unique aspect of the study is its less restric-
tive inclusion criteria which increases its generalizability.
All smokers, regardless of their desire to quit smoking
are invited to participate, resulting in the potential to
provide smoking cessation assistance to those who might
not otherwise receive it. PTSD is often not a solitary
diagnosis; 88% of men and 78% of women with PTSD
also have at least one other mental health diagnosis [41].
Whereas some trials examining PTSD and smoking have
excluded those with bipolar, substance abuse and schi-
zophrenia, this study does not make a blanket statement
to omit participants with those diagnoses. Ability to
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mary care or mental health provider, will allow partici-
pants with managed concurrent mental health diagnoses
to participate. We loosened our inclusion criteria during
the trial in order include participants who were smoking
less than ten cigarettes a day. This change occurred to
be more inclusive to interested participants. Thus, if suc-
cessful, the results can be applied inclusively to a large
population.
In conclusion, this study’s significance lies in its ability
to test the incorporation of written and telephone MI
based smoking cessation into an already established and
utilized mental health care coordination program.
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